VLP Therapeutics Receives FDA Clearance of Investigational New Drug Application and Initiates First Clinical Trial of VLPM01 Malaria Vaccine

Gaithersburg, MD– February 4, 2019 --  VLP Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a clinical trial of the Company’s VLPM01 malaria...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials